Literature DB >> 2694063

Surgical techniques and recidivism in cholesteatoma.

D R Edelstein1, S C Parisier.   

Abstract

Cholesteatoma is a difficult disease to treat as demonstrated by the relatively high recidivism rate attained by the best of surgeons. The concept of recidivism encompasses all reoccurrence of the disease, regardless of the theorized origins. This is a term that should be accepted so that some uniformity may be introduced into the evaluation of this disease. A standard reporting format that includes the extent of the disease, the eustachian tube function, the integrity of the ossicles, and a uniform description of the surgical procedure would enhance future evaluations of this disease. The future of otology still lies in finding new ways to eradicate this disease and to avoid recidivism.

Entities:  

Mesh:

Year:  1989        PMID: 2694063

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  7 in total

1.  Optical imaging with a high-resolution microendoscope to identify cholesteatoma of the middle ear.

Authors:  Lauren L Levy; Nancy Jiang; Eric Smouha; Rebecca Richards-Kortum; Andrew G Sikora
Journal:  Laryngoscope       Date:  2013-01-08       Impact factor: 3.325

2.  In vivo over-expression of KGF mimic human middle ear cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Naotaro Akiyama; Yasuaki Shibata; Haruo Takahashi; Tohru Ikeda; Takehiko Koji
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-20       Impact factor: 2.503

3.  Pathogenesis of middle ear cholesteatoma: a new model of experimentally induced cholesteatoma in Mongolian gerbils.

Authors:  Tomomi Yamamoto-Fukuda; Yoshitaka Hishikawa; Yasuaki Shibata; Toshimitsu Kobayashi; Haruo Takahashi; Takehiko Koji
Journal:  Am J Pathol       Date:  2010-04-22       Impact factor: 4.307

4.  Retrograde mastoidectomy with canal wall reconstruction versus intact canal wall tympanomastoidectomy for cholesteatoma with minimal mastoid extension.

Authors:  Masaomi Motegi; Yutaka Yamamoto; Taisuke Akutsu; Takahiro Nakajima; Masahiro Takahashi; Sayaka Sampei; Kazuhisa Yamamoto; Tomokatsu Udagawa; Yuika Sakurai; Hiromi Kojima
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-29       Impact factor: 3.236

5.  Aggressiveness of pediatric cholesteatoma. Do we have an evidence?

Authors:  Zareen A Lynrah; Jaimanti Bakshi; Naresh K Panda; N K Khandelwal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-08-22

6.  Topical application of 5-fluorouracil on attic cholesteatoma results in downregulation of keratinocyte growth factor and reduction of proliferative activity.

Authors:  Tomomi Yamamoto-Fukuda; Mariko Terakado; Yoshitaka Hishikawa; Takehiko Koji; Haruo Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-02       Impact factor: 2.503

Review 7.  Animal models of middle ear cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Haruo Takahashi; Takehiko Koji
Journal:  J Biomed Biotechnol       Date:  2011-04-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.